RUA Life Sciences plc (AIM:RUA)

Market Cap	8.84M +11.8%
Revenue (ttm)	4.11M +87.7%
Net Income	1,000.00
EPS	0.00
Shares Out	62.06M
PE Ratio	8,843.59
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,000
Average Volume	214,211
Open	13.86
Previous Close	14.25
Day's Range	13.86 - 14.22
52-Week Range	10.42 - 16.80
Beta	0.65
RSI	50.51
Earnings Date	Dec 11, 2025

About RUA Life Sciences

RUA Life Sciences plc, together with its subsidiaries, engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates through Biomaterials, Contract Manufacture, Vascular, and Structural Heart segments. The Biomaterials segment operates as depository of the Intellectual Property and licensing rights to a range of biostable and implantable polymers, including Elast-Eon and ECSil. The Contract Manufacture segment provides sub-contract manufacturin...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 40
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: RUA